The impact of the UPC on life science companies
Life science companies face unique patent issues, for example concerning relief, exemptions and supplementary protection. Bert Oosting, Andreas von Falck, Stanislas Roux-Vaillard, Stephen Bennett and Daniel Brook examine how these questions will be addressed in the proposed UPC
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: